Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation
Frequently silent until advanced stages, bone fragility associated with chronic kidney disease-mineral and bone disease (CKD-MBD) is one of the most devastating complications of CKD. Its pathophysiology includes the reduction of active vitamin D metabolites, phosphate accumulation, decreased intesti...
Main Authors: | Pablo Antonio Ureña Torres, Jean Claude Souberbielle, Martine Cohen Solal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/3/266 |
Similar Items
-
Bone fragility in patients with chronic kidney disease
by: Martine Cohen-Solal, et al.
Published: (2020-04-01) -
Estimation of the influence of exogenous factors on the vitamin D deficiency in pregnant women in Saint Petersburg
by: E L Khazova, et al.
Published: (2017-10-01) -
Serum 25‐hydroxyvitamin D concentration and infectious respiratory disease complex in shelter dogs
by: Jared A. Jaffey, et al.
Published: (2021-01-01) -
Determining correlation between changes in blood pressure and vitamin D levels: Analyzing influencing factors in hypertensive adults at Family Medicine Clinics
by: Aayesha Butt, et al.
Published: (2025-02-01) -
Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal
by: Er-Yuan Liao, et al.
Published: (2018-07-01)